NLS Pharmaceutics Warrant
NLSPW
NLSPW was delisted on the 30th of October, 2025.
5 hedge funds and large institutions have $5.17K invested in NLS Pharmaceutics Warrant in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
34% more capital invested
Capital invested by funds: $3.85K → $5.17K (+$1.32K)
0.07% more ownership
Funds ownership: 0.96% → 1.03% (+0.07%)
0% more funds holding
Funds holding: 5 → 5 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$2.99K |
| 2 |
CS
Clear Street
New York
|
+$606 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Altium Capital Management
New York
|
-$2.28K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$8 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WAM
1
Wolverine Asset Management
Chicago,
Illinois
| $3.19K | +$2.99K | +245,000 | New |
|
2
Hudson Bay Capital Management
Stamford,
Connecticut
| $821 | – | – | – |
|
|
CS
3
Clear Street
New York
| $753 | +$606 | +49,700 | +603% |
|
|
4
Citadel Advisors
Miami,
Florida
| $246 | -$8 | -668 | -3% |
|
|
AC
5
Armistice Capital
New York
| $163 | – | – | – |
|
|
ACM
6
Altium Capital Management
New York
| – | -$2.28K | -200,000 | Closed |
|
NLSPW Hedge Fund Activity: Q4 2024 in Review
5 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in NLS Pharmaceutics Warrant (NLSPW) for Q4 2024, worth a combined $5.17K — up 34% from $3.85K a quarter earlier.
Fund positioning in NLSPW was balanced in Q4 2024: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Wolverine Asset Management, opening a new position worth an estimated $2.99K. The largest seller was Altium Capital Management, exiting entirely with an estimated $2.28K sold.
- 5 institutional investors held NLS Pharmaceutics Warrant (NLSPW) as of Q4 2024, unchanged from Q3 2024.
- Funds reported $5.17K of NLS Pharmaceutics Warrant stock for Q4 2024, up 34% quarter-over-quarter.
- 1 fund opened new NLS Pharmaceutics Warrant positions in Q4 2024 and 1 closed out, a net change of 0 holders.
- The largest NLS Pharmaceutics Warrant buyer in Q4 2024 was Wolverine Asset Management, an estimated $2.99K added.
- The largest NLS Pharmaceutics Warrant seller in Q4 2024 was Altium Capital Management, an estimated $2.28K sold.
Based on aggregated 13F filings for Q4 2024.